Log In
Print
BCIQ
Print
Print this Print this
 

PH-797804

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionOral p38 mitogen-activated protein (MAP) kinase inhibitor
Molecular Target p38 mitogen-activated protein kinase (p38 MAPK) (MAPK14)
Mechanism of ActionMAP kinase (p38) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today